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Abstract The material studied was a thermoplastic blend
of corn starch with a poly(ethylene-vinyl alcohol) copoly-
mer, SEVA-C. The influence of both the material’s
exposed surface and enzyme concentration on degradation
kinetics was studied. As a-amylase is present in the blood
plasma, experiments were performed, varying the material
thickness and the a-amylase between 50 and 100 units/l, at
37C, lasting up to 90 days. Four different batches using
SEVA-C and starch samples of different thickness were
performed. The positive correlation between degradation
rate and the exposed material surface was confirmed, since
thin films with larger exposed surfaces were degraded
faster than thick square plates having the same total mass.
The degradation extent depends on the total amount of
amorphous starch present in the formulation rather than on
the amount of enzyme used and the minimum thickness to
ensure maximum degradation was estimated to be close to
0.25 mm.
1 Introduction
Natural, synthetic polymers and their composites are
widely used as biomaterials for biodegradable applications.
Biodegradable surgical implants are ideal for the repair and
regeneration of healing tissues, since the surgical procedure
for implant removal is avoided [1–4].
At an early stage of healing, the biodegradable implant
preserves the structure of the tissue and its function. In
time, the implant gradually decomposes and their function
is progressively transferred to the healed tissue. The time
necessary for this process depends on the type of poly-
mer, on its molecular weight and on the specific
biochemical and mechanical environment inside the body
[3, 4].
Apart from favourable physico-chemical and mechani-
cal properties, a biodegradable polymer to be used in
medical applications needs to be biocompatible in a spe-
cific environment and its degradation products should not
be cytotoxic [5]. The use of synthetic degradable polymers
as biomaterials implies they are biocompatible by them-
selves and the use of particular additives and/or processing
technologies should not interfere with the biocompatible
behaviour [5].
The development of degradable materials with adequate
mechanical properties may lead to a new range of small
load bearing applications for these systems. Combination
of polymers with bioactive ceramics is expected to mini-
mize the mismatch of mechanical properties of
bioceramics and natural tissue. Several polymer matrix and
bioactive ceramic reinforcements have been used to
develop composites intended to simulate bone properties.
Both bioinert and biodegradable polymers have been used
as matrices, aiming at both permanent and temporary
applications [6].
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1.1 Starch biomaterials
Starch blends have shown great processing versatility being
proposed for applications such as scaffolds for tissue
engineering [7, 8], drug delivery carrier systems [9–12],
hydrogels [9, 13], bone replacement/regeneration applica-
tions [14–17] and, more recently, tissue engineering
scaffolding [18–20]. Starch materials have adequate bio-
compatibility, non-cytotoxicity and suitable mechanical
properties [21–23].
The most studied systems are blends of starch with
ethylene-vinyl alcohol copolymer (SEVA-C), cellulose
acetate (SCA), poly(e-caprolactone) (SPCL) and poly(lac-
tic acid) (SPA) [6, 15, 16, 24].
Starch has poor mechanical properties and poor stability
caused by water absorption and processing. Some of these
problems can be overcome by physical or chemical mod-
ifications, including blending with the above mentioned
polymers [25].
1.2 Degradation of starch biomaterials
Studies using starch compounds showed that the starch
phase in the compound, being more hydrophilic, enhances
water infiltration [16, 26–28]. Starch blends degrade when
formulated with a-amylase, which catalyses the degrada-
tion of starch [24, 29, 30]. The enzyme catalyses the
hydrolysis of a-1,4-glycosidic linkages of starch to maltose
and dextrins. Typical starch degradation products are lower
molecular weight starch chains, fructose and maltose. It is
also worth noting that a-amylase is present not only in
saliva but also in human blood [31].
Previous results [29, 30] showed that the total mass loss
fraction of starch blends was around 35%, implying that
only part of the amorphous phase was released and
degraded to the solution, the remainder staying embedded
in the network structure. This structure hinders the enzyme
access to the starch molecules interspersed in the synthetic
insoluble component and EVA chains are likely to be
responsible for the non-degraded residual starch. The high
amount of non-degraded residual starch suggests the
possibility of optimising the material degradability by
deliberately increasing material porosity.
In this work, starch biomaterials were analysed in terms
of physical changes, degradation products and loss of
properties with time, when they were immersed in simu-
lated physiological solutions containing a-amylase for
periods of up to 90 days. These studies were carried out to
investigate the influence of thickness, exposed surface area
and enzyme concentration on the enzymatic degradation
mechanisms of starch blends. The investigation was also
performed to gain insight into how these materials will
behave as biodegradable thermoplastic materials.
2 Materials and methods
2.1 Materials
The material used was a thermoplastic blend of corn starch
with a poly(ethylene-vinyl alcohol) copolymer (60/40 mol/
mol), SEVA-C, supplied by Novamont, Italy (Mater-Bi
1128RR). Typically, the starch in this commercial blend is
50–60% (wt%) with 70% of amylopectin and 30% of
amylose. Four different batches were tested, using SEVA-
C and starch samples of different thickness (0.15 and
0.5 mm). Two batches consist of films of SEVA-C of 0.15
and 0.5 mm thickness, using always the same weight of
1.6 g. To perform the same fixed weight of 1.6 g, 2 films of
0.5 mm were used in one batch and 4 films of 0.15 mm
were used in another batch, according with Fig. 1.
Comparing with the other batches where square plates of
30 9 30 9 2 mm were used, the surface area corre-
sponded to 10 and 20 times (0.5 and 0.15 films with
95 cm2 and 190 cm2, respectively) the surface area of the
two other batches (square plates of 30 9 30 9 2 mm of
starch and SEVA-C with 10 cm2) (Fig. 2).
SEVA-C samples in individual containers (volume
approximately 50 cm3) were immersed for 90 days at pH 7.4
and placed in a temperature-controlled immersion circulator
(37C ± 1C), under continuous stirring (150 r.p.m.).
A Hank0s balanced salt solution (HBSS) without phenol red
Fig. 1 Batches using films of
(a) 0.5 mm (2 films) and (b)
0.15 mm (4 films) with 1.6 g
weight
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(HBSS Sigma reference H8264), with a-amylase (from
human saliva, Sigma reference A0521) was used to immerse
the samples. HBSS ionic composition is similar to the one of
human blood plasma. Control samples contained HBSS
without enzyme. The weight of samples was recorded and
used to determine the mass loss after the enzymatic degra-
dation. The concentration of a-amylase usually found in
human blood plasma is 50 U/l [14, 31]. To perform the
assays two concentrations of a-amylase were selected, 50
units/l and 100 units/l, in order to simulate the natural con-
ditions and duplicate the enzyme concentration.
The enzyme solution had an activity of 0.35 mg/unit/min
at pH 6.9 and 20C per gram of soluble starch (1% w/v). To
stabilize a-amylase, 1 mM calcium chloride was employed.
Square plates and films were used in in-vitro degrada-
tion experiments under strictly sterile conditions in a
laminar flux chamber. Samples were sterilised in a 10/90
gaseous mixture of ethylene oxide (EtO) and carbon
dioxide (CO2), with a cycle time of 20–22 h at 45C and a
chamber pressure of 180 kPa.
2.2 Analytical methods
2.2.1 Detection of starch and polysaccharides
The starch amount in the degradation solutions was deter-
mined by a colorimetric method: 100 ll of sulphuric acid
2 M and 0.5 ml of KI-I2 were added to a 5 ml of sample.
The absorbance of the solution was determined in a ELISA
reader (microprocessor controlled readers in 96 well
microplates) at 580 nm, being the respective concentration
obtained from a standard curve, with the same corn starch
used in the samples. The total amount of polysaccharides in
the degradation solutions was quantified using the Dubois
method [32] which is based on the addition of 1 ml of
phenol (5% w/v) and 5 ml sulphuric acid (95–97%) to 1 ml
of sample of the degradation solution. The absorbance of
the resulting mixture was determined with an ELISA reader
at 490 nm, using the same control as above.
2.2.2 Detection of reducing sugars
Enzyme activity was determined measuring reducing sug-
ars concentration in the degradation solutions by the
dinitrosalicylic acid method (DNS). DNS procedure is
based on the reduction of the 3,5-dinitrosalicylic acid to 3-
amino-5-nitrosalicylic acid under alkaline conditions, after
what the colour intensity is measured at 540 nm [33] in the
ELISA reader. The control sample was the same as above.
The respective carbohydrate concentration was obtained by
comparison with a standard curve.
2.2.3 Oligosaccharides detection by high performance
liquid chromatography
High performance liquid chromatography (HPLC) with
830-RI (Jasco, Japan) refraction index detection and a 880-
PU pump (Jasco) was used to separate sugar derivatives
from the starch hydrolysates of the degradation solutions.
Commercial standards were used for the calibration of
the Chrompack carbohydrates Ca column. A Chrompack
guard column at 90C with ultra-pure water as eluent
(0.5 ml/min), was kept at a 6500–7000 kPa pressure. Elu-
ent was filtered through a 0.22 lm sterilized membrane
previously degassed with helium, and kept in a container to
preclude contamination by airborne bacteria or fungi.
Sorbitol (1 g/l) was used as internal standard. Samples
were also filtered through 0.22 lm filters. Three replica of
each sample were analyzed. A standard curve was obtained
using different standard concentrations.
2.2.4 Scanning electron microscopy (SEM)
Modifications on the surface morphology and intercon-
nectivity of SEVA-C specimens and films with enzymatic
physiological solution, as a function of immersion time,
were characterized by SEM in a Leica Cambridge S360
microscope. Before analysis, plates and films were cleaned
and dried at 50C for 1 week and kept in a desiccator. A
non-immersed specimen, stored at controlled environment
conditions was used as control.
2.2.5 Statistical analysis
Student0s t-test for independent samples was performed to
test differences among samples. Results were expressed as
mean ± standard deviation. Differences between experi-
mental results were analyzed according to Student t-test,
Fig. 2 Setup of the samples in
each assay. (a) Squared plate;
(b) films of 0.5 mm and (c)
films of 0.15 mm
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with p \ 0.05 considered statistically significant. Student0s
t-test was plotted along with mean values based on 95%
confidence intervals.
3 Results
3.1 Starch amount in the degradation solution
The amount of starch released to the solution was measured
in all batches. Figure 3 shows the results obtained using a
starch square plate in solution.
Starch was also available on degradation solution after
immersion with a-amylase using 0.5 mm films and square
plates of SEVA-C.
Figures 4 and 5 show the results for SEVA-C square
plate and 0.5 mm films with 50 and 100 units/l a-amylase.
3.2 Reducing sugars in the degradation solution
The amount of reducing sugars in the degradation solutions
was measured by DNS for batches with 50 units/l and 100
units/l a-amylase. Figures 6 and 7 shows the results
obtained with 50 units/l and 100 unit/l a-amylase,
respectively.
3.3 Polysaccharides in the degradation solution
The amount of polysaccharides released to the solution was
quantified by the Dubois method, as previously described.
Figures 8 and 9 show the polysaccharides released to
solution for 50 and 100 units/l a-amylase.
Qualitative changes on SEVA-C surface morphology in
contact with the enzymatically active solution were also
followed by SEM. Figure 10 shows films micrographs
before and after 90 immersion days. It was also notice that
starch squared plates was completed fragmented after a few
immersion days, so it was not possible to observe the
structure.
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Fig. 3 Mass of starch (square plate) released to the solution with 50
units/l a-amylase, per initial specimen mass (1.6 g) in 50 ml of
solution, as a function of immersion time. Each point is the mean of 2
duplicates (4 values in all); error bars are 95% confidence intervals of
each mean
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Fig. 4 Mass of starch released to the solution with 100 (j) and 50
(h) units/l a-amylase, per initial specimen (SEVA-C squared plate)
mass (1.6 g) in 50 ml of solution, as a function of immersion time.
Each point is the mean of 2 duplicates (4 values in all); error bars are
95% confidence intervals of each mean
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Fig. 5 Mass of starch released to solution with 100 (j) and 50 (h)
units/l a-amylase, per initial specimen (SEVA-C 0.5 mm films) mass
(1.6 g) in 50 ml of solution, as a function of immersion time. Each
point is the mean of 2 duplicates (4 values in all); error bars are 95%
confidence intervals of each mean
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Fig. 6 Mass of glucose released to the solution with 50 units/l a-
amylase, per initial specimen (squared plates of SEVA-C and starch
and films of SEVA-C) mass (1.6 g) in 50 ml of solution, as a function
of immersion time. Each point is the mean of 2 duplicates (4 values in
all); error bars are 95% confidence intervals of each mean
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4 Discussion
Analysing Fig. 3, starch released to the solution after 10-
day immersion. Starch was completely fragmented, due to
the polymer swelling and water lubrication, confirming at
the same time the enzymatic action on the starch molecule.
The release of starch from the surface of the blends to the
bulk solution is also limited by the porosity of the material.
Rupture of polymeric chains exposes subsequently amylose
and amylopectin, allowing thereby enzyme to proceed its
action directly on these molecules.
The amount of starch released to the solution with 100
units/l a-amylase is higher than the one obtained for all the
experiments using 50 units/l, even though the quantity
released, 0.08%, is still rather small (Fig. 4).
Diffusion of water and access of water-soluble enzymes
into the blend is expected to be less for miscible SEVA
region than for a pure starch domain (Figs. 3 and 4).
During processing, thermal-oxidative degradation
enhances the release of non-polymerized monomers or
oligomers soluble in water, as quantified by the method.
Starch destruction depends also on the material micro-
structure, since the starch surrounded by EVA chains is less
susceptible to degradation, rendering more difficult the
external and internal starch mass diffusion.
The release of starch from the surface to the bulk is also
limited by the porosity of the material (Figure 10) and by
transport limitation from inside to the surface and from this
to the bulk zone (inner and outer diffusion). Global deg-
radation rate is controlled by the slowest step. In fact, the
enzyme molecule is too large to allow its diffusion through
the polymeric matrix; therefore, only starch at or close to
the surface would be available for enzymatic attack. To
increase the accessibility of inner starch particles, the
percentage of starch in the material should be higher.
Degradation of starch would then create a connected net-
work of pores and voids that would enable the transport of
enzyme to the inner region of the material.
Figure 6 compares the results of glucose release in all
the batches using 50 unit/l of alpha-amylase. The differ-
ence between SEVA-C material and square plates is
significant, 100% percentage meaning total enzymatic of
the specimen to glucose. The difference between SEVA-C
square plates and films is also evident, confirming the
positive effect of the exposed surface, since the total mass
is fixed (1.6 g). The initial linear part of the degradation
curve corresponds to the fast hydrolysis phase, and tended
to stabilise reaching a constant 20% (w/w) of glucose, after
a 60-day immersion. This was expected, since a-amylase
randomly hydrolyses a-1,4-glucosidic bonds of starch into
dextrins.
Only small molecular weight fragments were released at
early stages of degradation, and therefore no significant
changes in the total mass of the specimen were observed. It
is noticeable the difference between films and square
plates, as happened also with 100 units/l a-amylase
(Fig. 7). As all the binding and active sites a-amylase are
saturated, since the enzyme concentration is much lower
than the starch concentration, there was no difference
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SEVAC square plate 0.5 mm films 0.15 mm films
Fig. 7 Mass of glucose released to solution with 100 units/l a-
amylase, per initial specimen (squared plates and films) mass (1.6 g)
in 50 ml of solution, as a function of immersion time. Each point is
the mean of 2 duplicates (4 values in all); error bars are 95%
confidence intervals of each mean
0
20
40
60
80
100
0 20 40 60 80 100
Immersion time (days)
g 
po
ly
sa
cc
ha
rid
es
/g
 in
iti
al
 
sp
ec
im
en
 (%
)
squared SEVAC 0.5 mm films 0.15 mm films Squared starch
Fig. 8 Mass of total polysaccharides released to solution with 50
units/l a-amylase, per initial specimen (squared plates and films of
SEVA-C and starch) mass (1.6 g) in 50 ml of solution, as a function
of immersion time. Each point is the mean of 2 duplicates (4 values in
all); error bars are 95% confidence intervals of each mean
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Fig. 9 Mass of total polysaccharides released to solution with 100
units/l a-amylase, per initial specimen (squared plates and films) mass
(1.6 g) in 50 ml of solution, as a function of immersion time. Each
point is the mean of 2 duplicates (4 values in all); error bars are 95%
confidence intervals of each mean
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between 0.5 and 0.15 mm films on the amount of released
products, despite the variation on the exposed surface
between them (90 and 190 cm2). When the enzyme con-
centration rises, SEVA-C surface becomes completely
coated with enzyme molecules and the reaction rate
becomes proportional to the concentration of reactive sites
(effective concentration). Enzyme kinetics depends directly
on the exposed surface but not on the total mass of
degradable material, since the amount of released products
on materials with the same mass and different surface is
distinct.
There is no significant difference between square plates
and films on the final glucose amount as shown in Figs. 6
and 7. The initial hydrolysis phase is faster with 100 units/l
a-amylase but tends to the same limit, which is probably
related with the limiting number of active and binding sites
of the enzyme.
Total amount of polysaccharides was also quantified for
50 and 100 unit/l alpha-amylase as demonstrated in Figs. 8
and 9. The amount of polysaccharides released to solution
increased in both assays, evidencing the enzyme action on
degradation rate. Stabilization of weight mass loss as a
function of ageing is associated to internal diffusion limi-
tation of monosaccharides coming from the inner part of
the material.
The large difference between square plates and films of
SEVA-C and starch (Fig. 8) is also noticeable. When in
solution, enzymatic reaction converts starch completely to
short chain monosaccharides. By comparing Figs. 8 and 9,
it is clear that increasing enzyme concentration to 100
units/l did not lead to more released products, owing to the
unfavourable starch structural arrangement inside the
material. No significant differences were seen between 50
and 100 units/l a-amylase for plates or films. The low mass
percentage released after 90 days may also be attributed to
the nature of the blend, as the enzyme molecules can not
reach the starch molecules strongly interpenetrated in the
synthetic insoluble component.
The presence of non-reactive ethylene also reduced
mass loss, as less accessible hydroxyl groups are present in
the blend. Moreover, the low porosity and the lack of
connectivity among starch sites avoid complete degrada-
tion of this material. Other malto-oligosaccharides might
be expected to be present in the solution, as a-amylase
cleaves starch glycosidic linkages randomly.
As to compare changes on surface morphology before
and after degradation, Fig. 10 shows the differences
between the film control (before degradation) and after
degradation. Porosity, roughness and heterogeneity surfaces
increased as a function of immersion time, as detected on
surface microstructure between control (smooth) and more
degraded samples (90 days) being more rough.
5 Conclusions
The effect of SEVA-C thickness (different exposed sur-
face) and enzyme concentrations on starch blends
biodegradation mechanisms was studied and led to the
following conclusions:
– Higher enzyme concentration (100 units units/l a-
amylase) increases only the initial degradation rate of
amorphous phase, such as starch and other sugar chains
like maltotriose, maltose and glucose to solution.
Nevertheless, for longer immersion times the same
equilibrium value is attained for all batches, which is
related with the limited reaction sites and starch
structural organization inside the material.
– Square starch plate was completed fragmented by
enzymatic action. The amount of accessible starch in
the composite proved to be a more important factor
than the quantity of enzyme used to promote
degradation.
– No significant differences between SEVA-C 0.5 and
0.15 mm films were observed in the amount of
saccharides released to solution, although they present
different exposed surfaces. There seems to be enzyme
saturation at the reaction sites, the same final amount of
degraded products was obtained.
– The minimum thickness to ensure maximum degrada-
tion may be estimated to be close to 0.25 mm (half of
Fig. 10 SEM micrographs of
SEVA-C surfaces of control
(before degradation) and after
90 immersion days, respectively
(x 1500). (a), (b) 0.5 mm films
and (c), (d) 0.15 mm films. The
images represent dried samples
after immersion periods
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the 0.5 mm film thickness), as no differences were
obtained between SEVA-C 0.5 and 0.15 mm films. The
degradation rate depends directly on the exposed
surface and not on the total mass.
– The release of starch from the inner structure is also
limited by the way it is organised inside the thermo-
plastic blend, limiting thus the inner and external
diffusion and mass transfer of starch, precluding the
enzyme access to the innermost starch molecules.
– Chemical composition, processing conditions and the
structure of the starch polymeric blend influence the
enzymatic hydrolysis rate by limiting the accessibility
of enzymes to the starch substrate influencing, there-
fore, their degradation profiles.
Further optimization and control of the main physical
material properties might improve enzymatic degradation
processes for specific applications. The proper choice of
material thickness (surface structure), surface porosity and
roughness and enzyme concentration may elicit the control
of the degradation rate.
Nevertheless, the released products should be metabo-
lized and excreted by normal human mechanisms, and in vivo
assays are necessary to confirm particle resorption and their
behaviour inside the body in temporary tissue replacement.
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